Clinical Trial Update: Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effects of dexmedetomidine during radiofrequency ablation of abdominal tumors. The study involving cancers of the kidney/renal pel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Renal Cell Carcinoma
• Renal Pelvis Urothelial Carcinoma

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Uppsala University Hospital | Conditions: Cancer of Kidney and Renal Pelvis, Cancer of Liver | Phase 4 | Status: COMPLETED